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Abstract
Background: Child maltreatment is a significant public health problem. Group Family Nurse Partnership (gFNP) is a
new intervention for young, expectant mothers implemented successfully in pilot studies. This study was designed
to determine the effectiveness and cost-effectiveness of gFNP in reducing risk factors for maltreatment with a potentially
vulnerable population.
Methods: A multi-site, randomized controlled, parallel-arm trial and prospective economic evaluation was conducted,
with allocation via remote randomization (minimization by site, maternal age group) to gFNP or usual care. Participants
were expectant mothers aged below 20 years with at least one live birth, or aged 20–24 years with no live births and
with low educational qualifications. Data from maternal interviews at baseline and when infants were 2, 6 and 12 months,
and video-recording at 12 months, were collected by researchers blind to allocation. Cost information came from weekly
logs completed by gFNP family nurses and other service delivery data reported by participants. Primary outcomes
measured at 12 months were parenting attitudes (Adult-Adolescent Parenting Index, AAPI-2) and maternal sensitivity
(CARE Index). The economic evaluation was conducted from a UK NHS and personal social services perspective with
cost-effectiveness expressed in terms of incremental cost per quality-adjusted life year (QALY) gained. The main
analyses were intention-to-treat with additional complier average causal effects (CACE) analyses.
Results: Between August 2013 and September 2014, 492 names of potential participants were received of whom 319
were eligible and 166 agreed to take part, 99 randomly assigned to receive gFNP and 67 to usual care. There were no
between-arm differences in AAPI-2 total (7 · 5/10 in both, SE 0.1), difference adjusted for baseline, site and maternal age
group 0 · 06 (95% CI − 0 · 15 to 0 · 28, p = 0 · 59) or CARE Index (intervention 4 · 0 (SE 0 · 3); control 4 · 7 (SE 0 · 4); difference
adjusted for site and maternal age group − 0 · 68 (95% CI − 1 · 62 to 0 · 16, p = 0 · 25) scores. The probability that gFNP is
cost-effective based on the QALY measure did not exceed 3%.
Conclusions: The trial did not support gFNP as a means of reducing the risk of child maltreatment in this population but
slow recruitment adversely affected group size and consequently delivery of the intervention.
Trial registration: ISRCTN78814904. Registered on 17 May 2013.
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Background
Recent estimates show that suboptimal parenting is a major
public health issue [1]. Interventions to enhance parenting
during the first year can reduce the risk of maltreatment
and promote optimal child outcomes, as highlighted in UK
policy documents [2, 3]. However, there is little evidence
about “what works” to support vulnerable parents during
pregnancy and infancy. Nurse Family Partnership (NFP),
extending from pregnancy until children are 24 months
old, is commonly identified from studies in the USA as a
program with high-quality evidence for reducing the risk of
neglect and abuse [4], although this has yet to be demon-
strated in the UK [5]. Trials of NFP in the USA and the
Netherlands found that it was particularly beneficial for
women with “low psychological resources,” namely a
combination of lower intelligence, mental health problems
and low self-efficacy [6, 7].
The NFP program was introduced in the UK in 2007,
renamed the Family Nurse Partnership (FNP) and
offered only to first-time mothers under the age of 20
years [8]. Group FNP was developed to be offered in a
group context to parents not eligible for FNP but whose
children were at risk of poor outcomes, designed to use
the expertise of the FNP nurses and learning from the
FNP [9]. Like FNP, the group program aims to help
parents develop their health, wellbeing, confidence and
social support in pregnancy, their children’s health and
parenting in the first year of life, and to raise aspirations
about future education and employment [9]. The main
difference from existing group support in the UK for
expectant mothers or women with new babies, such as
that offered by midwives and health visitors [10] or in
Sure Start Children’s Centers [11], is that gFNP spans
pregnancy and infancy, extending over 18 months and is
based on a program with evidence for reducing the risk
of child maltreatment. The gFNP program, delivered by
two FNP family nurses (FNs) (one of whom is a
practicing midwife), uses materials and the approach of
the FNP program and practitioners also conduct routine
antenatal care and infant health checks, based in part on
the “Centering Pregnancy” program [12].
It was demonstrated in two implementation studies [13]
that gFNP is acceptable to the proposed target population,
potentially vulnerable mothers who are young but not
eligible for FNP (aged under 20 years and expecting a second
or subsequent child; aged 20 to 24 years and expecting a first
child and with low educational qualifications). Following UK
Medical Research Council (MRC) guidelines for evaluating
complex interventions [14] the gFNP program’s impact was
assessed using a randomized controlled trial (RCT).
The objective of the research was to compare families
offered gFNP in early pregnancy in conjunction with usual
publicly funded health and social care services with a
control group receiving usual services. Outcomes were
assessed when infants were 12 months old with two
primary outcomes, self-reported attitudes to parenting and
observations of maternal sensitivity. There were also eight
secondary outcomes: at 12 months, maternal depression
symptoms, maternal stress, maternal sense of competence,
maternal smoking, alcohol and drug use, social support,
relationship violence, observed infant cooperativeness; and
breastfeeding to 6 months.
Methods
Study design
The study’s objective was to determine whether gFNP,
compared to routine antenatal and postnatal care, could
improve parenting, and hence reduce risk factors for
maltreatment in a vulnerable population and also be
cost-effective.
The design was a multi-site, blinded, randomized
controlled, parallel-arm trial and prospective economic
evaluation with eligible pregnant women at seven
locations in England allocated (minimized by site and
maternal age group) to one of two arms: (1) gFNP and
(2) usual care. All participants (both arms) were eligible
to receive usually provided publicly funded health and
social care. Baseline data were collected in early pregnancy
with follow-up when infants were 2 and 6 months old and
the primary endpoint at 12 months.
The study was granted approval by the UK National
Research Ethics Service Committee South West-Frenchay
(REC reference 13/SW/0086).
Study setting and participants
Family Nurse Partnership teams were eligible to take
part in the trial if they were experienced in delivering
FNP and had at least one FN who had notified their
intention to practice as a midwife. Sites responded to an
invitation from the FNP National Unit to take part,
demonstrating that sufficient women of the relevant age
and parity had given birth in the previous year, and con-
firming good links with community midwifery, who also
signed the expression of interest. Seven sites agreed to
take part, representing London (two sites), the Midlands
(two sites), the North East (one site) and the North West
of England (two sites).
Women eligible for the trial were expectant mothers
with a gestation of 16 to 20 weeks, with expected delivery
dates (EDDs) within approximately 10 weeks of each
other, for each group in each site. They were either aged
below 20 years at their last menstrual period (LMP) with
one or more previous live births, or aged 20–24 at LMP
with no previous live births and with low educational
qualifications, defined as neither mathematics nor English
language GCSE at grade C or higher; if both, then no
more than four GCSEs at grade C or higher. They had to
be able to provide consent and to speak English. Women
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who had previously received FNP and those with psychotic
mental illness were not eligible.
Recruitment
Full details of the recruitment can be found in the study
protocol [15]. The trial commenced in February 2013,
recruitment and baseline data collection commenced in
July 2013, continuing to September 2014. Recruitment
was in three phases, each separated by approximately 12
weeks, so that FNP teams could offer more than one
group. Potential participants were identified from
records by community midwives, and then after some
difficulties in identifying a sufficient number [16] also by
FNP midwives and Clinical Local Research Network
(CLRN) research midwives, based on their age, parity
and gestation from midwifery records. After written or
telephone agreement for the researcher to contact the
potential participant, a telephone contact confirmed
eligibility by asking about educational qualifications and
any psychotic mental illness. If they were eligible and
interested in the study the researcher arranged a home
visit so that written consent could be obtained and
baseline information collected. Following baseline data
collection their contact details were entered into a secure
database which generated an identification number.
Randomization and blinding
Randomization was overseen by the London School of
Hygiene and Tropical Medicine Clinical Trials Unit
(LSHTM CTU). The unique identification number
(which included a site identifier) and age at LMP of
eligible consenting mothers-to-be were passed to the
central randomization service at the Health Service
Research Unit (HSRU), University of Aberdeen using an
automated telephone procedure. Minimization criteria
(site, and age group below 20 years, 20–24 years) were
used to ensure a balance of key prognostic factors. Due
to low recruitment, randomization was changed from
1:1 to 2:1 in December 2013 after approval from the
Trial Steering Committee (TSC), Data Monitoring
Committee (DMC) and Research Ethics Committee
(REC). Allocation to one of two arms was securely
computer-generated and delivered by email to LSHTM
which conveyed the information to study participants
by post and conveyed to each gFNP team the names and
contact details of women allocated to the intervention arm
by fax or password-protected email, receiving confirmation
of receipt by email. Participants could not be blind to
allocation as they knew whether or not they had been
offered gFNP, and gFNP practitioners were not blind to the
intervention participants but had no knowledge of the
control group. Service providers other than gFNP personnel
may or may not have been blinded depending on what study
participants chose to discuss when receiving usual care. The
research team members responsible for collecting the
questionnaire data, including the principal investigator
(PI), the trial manager, the interviewers and also those
scoring the videos for the CARE Index, were blind to
treatment allocation.
Procedures
Study intervention: Group FNP (gFNP) is designed to
run from the first trimester of pregnancy until infants
are 12 months old with 44 group meetings in the
curriculum, 14 covering pregnancy and 30 covering
infancy [17]. It is delivered to a group of women living
in relatively close proximity to each other, with similar
expected delivery dates (range 8–10 weeks) [9]. Meetings
last around 2 h, are held in children’s centers, health
centers or other suitable community facilities in the local
areas served by the FNP teams. Sessions were facilitated
by two experienced FNP FNs one of whom had notified
their intention to practice as a midwife. The two FNs
exchanged the roles of active leader (facilitating a topic
and activity) and active observer, noticing behaviors and
body language of members and stepping in to support
the leader and maintain a positive and inclusive group
environment.
The gFNP program includes content to: improve mater-
nal health and pregnancy outcomes, improve child health
and development by helping parents provide more sensitive
and competent care; and to improve parental life course by
helping parents develop effective support networks, plan
future pregnancies, complete their education, and find
employment [9]. The curriculum domains are: mother’s
personal health; the maternal role; maternal life course:
family and friends; environmental health; and related health
and human services, with referrals made when necessary.
In general all the content domains are covered to a greater
or lesser extent in each of the meetings, varying according
to a detailed manual. The gFNP curriculum materials and
activities were modified from those used to deliver FNP to
reflect group administration. They were designed to avoid a
lecture context but to facilitate interaction between group
members and between group members and the nurses,
providing a range of engaging, often “hands-on” activities.
In particular, gFNP had a particular focus on enhancing
social support and social networks through dialog between
group members, which is not a specific focus of home-based
FNP [9, 17].
Specific to the gFNP program and following national
guidelines [18], the FN midwife provided routine
antenatal care during the meeting, taking an approach
based on the Centering Pregnancy program [12, 19, 20]
which encourages women to monitor their own health
(e.g., by testing their own urine, listening to the fetal
heartbeat). The Centering Pregnancy approach was
perceived to correspond well with the gFNP aims in
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that both focus on developing self-efficacy and encouraging
women to be more self-aware [9]. Once infants were born
both FNs were involved in routine infant checks, conducted
according to the UK National Health Service (NHS) Healthy
Child Program (HCP) [10].
Appreciation of the diversity of group members is
central to how the nurses deliver the content, especially
for some emotive topics such as “safe relationships for
our children” [9]. While there is a curriculum for each
meeting the nurses were sensitive to the need for “agenda
matching” related to particular issues raised; this requires
the practitioners to listen to the issues that are upper-
most for the group members and agree how these can be
met while at the same time ensuring that the session
agenda is realized and behavior adaptation is progressed
for everyone. In addition to modeling of infant care, they
model respectful relationships and turn-taking [21], behav-
iors that are expected to be of benefit to any group members
with poor social skills, especially if they are experiencing diffi-
cult interpersonal relationships [9]. Study participants
allocated to gFNP could also access any aspect of the HCP
usual care that they wished, independently or with the
guidance of the gFNP nurses.
Control – usual care: complete details of the care of-
fered through the NHS to pregnant women and those
with infants up to age 1 year at the time that the
research was conducted can be found in the UK HCP
[10 l]. The HCP, led by health visitors, is delivered
through integrated services that bring together Sure
Start children’s center staff, general practitioners,
midwives, community nurses and others. In summary,
it offers every family a program of screening tests, im-
munizations, developmental reviews, and information
and guidance to support parenting and healthy choices.
There are core universal elements provided for all fam-
ilies with additional progressive, preventive elements
for those with medium or high risk. The universal pro-
gram includes a neonatal examination, a new baby re-
view at about 14 days, a 6- to 8-week baby examination
and a review by the time the child is 1 year old and at 2
to 2.5 years old.
The aims of the HCP are to develop strong parent-
child attachment and positive parenting, resulting in bet-
ter social and emotional wellbeing among children; care
that helps to keep children healthy and safe; healthy
eating and increased activity, leading to a reduction in
obesity; prevention of some serious and communicable
diseases; increased rates of initiation and continuation of
breastfeeding; readiness for school and improved learning;
early recognition of growth disorders and risk factors for
obesity; early detection of – and action to address – develop-
mental delay, abnormalities and ill-health, and concerns
about safety; identification of factors that could influence
health and wellbeing in families; and better short- and
long-term outcomes for children who are at risk of social
exclusion.
There is a focus on supporting mothers and fathers to
provide sensitive and attuned parenting, in particular
during the first months and years of life. From the 12th
week of pregnancy women are encouraged to see a
midwife or maternity healthcare professional for a health
and social care assessment of their needs, risks and
choices.
Data collection
Data collection was conducted by field researchers mak-
ing four visits to participants’ homes (baseline in early
pregnancy, when infants were 2 months, 6 months and
12 months old), when they administered structured
questionnaires and at 12 months (if additional consent
was given) they made a 3- to 5-min video-recording of
the mother and infant together, presented with a
standardized set of toys. Participants were given a “High
Street” voucher for £20 at each home visit. Measures
used at each time point are presented in Table 1 with
full details in the published protocol [15]. Researchers
sent completed questionnaires by post to LSHTM CTU
and checks were made for receipt. Videos of play inter-
actions were transferred by fieldworkers from camera to
encrypted USB flash drives with AES 256-bit military-level
security, sent by recorded delivery to the PI, with files de-
leted from the camera by the fieldworkers. Recordings were
decrypted and saved with full anonymization of filenames on
a dedicated drive separate from any other study information.
Outcomes
Two primary outcome measures at 12 months were used:
the revised Adult-Adolescent Parenting Inventory (AAPI-2)
[22], a 40-item self-report measure of attitudes to parenting
previously found to discriminate between abusive and non-
abusive parents [22]; and maternal sensitivity rated by ob-
servation using the CARE Index, which can range from 0
to 14 with scores of 0–4 in the risk range for child maltreat-
ment [23]. Eight pre-specified secondary outcomes assessed
infant cooperativeness [23]; maternal depression [24]; stress
[25]; sense of competence [26]; social support [27]; smoking,
alcohol and drug use; relationship violence; and breastfeeding
to 6 months (see [15] for full details and Table 1).
To assess maternal quality-adjusted life years (QALYs)
for the economic evaluation, the EuroQol EQ-5D-5 L
measure [28] was administered at each time point (see
Table 1). This five-dimension health status classification
system can be converted to a multi-attribute utility score
by applying a national tariff [29].
Adverse events were assessed using information from
research midwives, maternal interview or pre-paid change
of circumstances cards, and categorized as adverse
(hospitalization of mother or infant other than for delivery)
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or severe (loss/termination of the pregnancy, congenital
anomaly or birth defect, persistent or significant disability
and death of either mother or infant). Severe events were
reported to the REC within 15 days of the PI becoming
aware of the event.
Statistical analysis
For the individually randomized trial we proposed to
recruit sufficient mothers and babies (families) to detect
a difference between arms of 0 · 5 standard deviations
(SDs), with 90% power at a significance level of 0 · 05
(two-tailed), considered to represent a moderate size of
effect [30]. Basing calculation on the AAPI-2 [22], very
conservatively assuming a correlation of 0 · 4 between
pre- and post-intervention scores, at least 71 families
were needed in each arm of the trial to detect this differ-
ence. Allowing for an expected 30% dropout rate (based
on the first two applications of the program in England)
we would need to recruit 84 families per arm of the trial.
We therefore proposed, conservatively, to recruit a 100
families per arm (N = 200). The proposed sample size
would similarly allow us to detect a change of approxi-
mately 0 · 5 SDs in the CARE Index maternal sensitivity
score [23]. If this was achieved we expected to be able to
detect a difference at follow-up between arms of the trial
of approximately 1 · 2 with 90% power and a 5% level of
significance. Based on additional calculations when changing
the allocation ratio following recruitment difficulties
[16], a sample size of 166 participants would have
81% power to detect an effect of 0 · 5 SDs in the pri-
mary outcomes.
Primary analyses were by intention-to-treat (ITT), i.e.,
based on random allocation regardless of receipt of
program. Follow-up was not restricted to those receiving
the program. Analyses included adjustment for baseline
measure of the outcomes where available (ANCOVA)
and also an “adjusted” analysis that additionally included
adjustment for the minimization factors site and mater-
nal age group. The complete case analysis provides an
unbiased estimate of the ITT effect under a “missing-at-
random” assumption but, in addition to the primary
analyses, complier average causal effect (CACE) analyses
[31] were conducted to estimate a measure of the effect
of the intervention on those participants who received it
as intended by the original allocation. Where outcomes
were collected at multiple time points, random-effects
models, using a likelihood-based approach, were simul-
taneously fitted to the outcomes at all the time points
that they were measured so that data from all the
participants contributed to the analyses, even if there
Table 1 Measures and data collection timetable
Measure Baseline,
pregnancy
Infant 2
months
Infant 6
months
Infant 12
months
Primary outcomes
1. Revised Adult-Adolescent Parenting Inventory (AAPI-2) [22] √ √
2. Maternal sensitivity, CARE Index [23] √
Secondary outcomes
1. Infant cooperativeness, CARE Index [23] √
2. Maternal depression, Edinburgh Postnatal Depression Scale (EPDS) [24] √ √ √ √
3. Maternal stress, Parenting Stress Index, Short Form (PSI) [25] √ √
4. Maternal competence, Parenting Sense of Competence (PSOC) scale [26] √ √
5. Social support, Medical Outcomes Study (MOS) Social Support Survey
[27]
√ √
6. Maternal smoking, alcohol and drug use, questions developed for the
study
√ √ √
7. Relationship violence, questions developed for the study √ √
8. Breast feeding (plans and actual), questions developed for the study √ √ √
Economic outcomes
1. Maternal quality of life (EQ-5D 5 L) [28] √ √ √ √
2. Service use, questions developed for the study √ √ √
Other information collected
Family demographic updates √ √ √
Baby demographics √
Infant immunizations √ √
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were missing data at some of the follow-up points The
statistical analysis plan as agreed with the DMC in De-
cember 2014 was for the primary analysis to exclude all
data outside pre-specified windows, i.e., after 12 months
plus 60 days, 6 months plus 45 days and 2 months plus
30 days. However, in addition, sensitivity analyses were
conducted with all data including those outside the win-
dows. For the primary outcome of the AAPI-2 [22] a lin-
ear regression model was used to estimate a mean
difference in 12-month AAPI-2 scores between the two
arms of the trial. For the primary outcome maternal sen-
sitivity score [23] a mixed-effects model was planned
with a random effect at the mother level (to allow for
multiple births) to estimate a mean difference in mater-
nal sensitivity score between the two arms of the trial.
However, only one set of twins was available for this
analysis and their responses were identical. Therefore, it
was not possible to include a random effect and the ana-
lysis was carried out at the mother level using a linear
regression model.
For the secondary outcomes, appropriate generalized
linear models were used to examine the effect of the
intervention. Odds ratios and mean differences are
reported with 95% confidence intervals (CIs). As for the
primary outcomes, where continuous measures were
available at baseline they were adjusted for in the analysis
with additional analyses adjusted for site and maternal age
group. Where there was evidence of non-normality in the
continuous outcome measures, non-parametric bootstrap-
ping with 1000 samples was used to estimate the effect of
the intervention and bias-corrected CIs are reported [32].
Where this was done, p values were estimated using per-
mutation tests. Statistical analyses were conducted using
Stata version 14. An independent Data Monitoring Com-
mittee (DMC) oversaw the trial.
Economic evaluation
A within-trial economic evaluation was conducted from
a UK NHS and personal social services perspective.
Primary research methods estimated the costs of deliver-
ing gFNP, including development and training of accre-
dited providers, the cost of delivering the group
sessions, participant monitoring activities, and any
follow-up/management. This primarily involved asking
each of the gFNP practitioners in each site to prospect-
ively complete detailed weekly activity logs outlining the
cost of delivering each gFNP session, including costs as-
sociated with preparation time, program delivery time,
indirect administrative activities, home visits and tele-
phone contacts, as well as gFNP-related training and
supervision activities. The weekly activity logs also re-
corded the mode, distance and time spent traveling by
each practitioner as a result of gFNP-related activities. They
also recorded additional expenditures associated with
refreshments, materials, cards or gifts, participant travel, part-
ner travel, child-care costs and miscellaneous expenditures
associated with weekly gFNP-related activities. The costs of
venue hire were estimated separately within each site. The
total costs of delivering the gFNP program across each group
and site were subsequently converted into group and site-
specific estimates of average cost per session per attending
woman using separately collected attendance data for each
group within each site. Broader resource utilization was cap-
tured through maternal questionnaires completed at each
follow-up point and provided profiles of hospital and com-
munity health and social services received by each trial par-
ticipant (and, in the case of the postpartum questionnaires,
their baby). Information was also collected regarding use of
legal services and costs borne by the trial participants or their
family members or friends as a result of the trial participants’
(and, in the case of the postpartum questionnaires, their
baby’s) health status, over the relevant time horizons. Unit
costs (£, 2014–2015 prices) were collected from national
sources in accordance with guidelines and attached to re-
source use. Health utilities generated from EuroQol EQ-5D-
5 L [28] responses were used to estimate QALY profiles for
each woman, calculated as area under the baseline-adjusted
utility curve, assuming linear interpolation between utility
measurements. Costs and QALYs accrued by each trial
participant beyond the first 12 months of follow-up were
discounted at 3 · 5% as recommended by the National
Institute for Health and Care Excellence (NICE) [33].
Multiple imputation using chained equations [34] and
predicted mean matching was carried out on the EQ-5D-5
L, as well as cost estimates, at 2, 6 and 12 months postpar-
tum [35]. Mean (standard error (SE)) costs by cost cat-
egory and mean (SE) total costs were estimated by trial
allocation arm for all time periods.
Cost-effectiveness results are reported as incremental cost-
effectiveness ratios (ICERs), calculated as the difference in
mean costs divided by the difference in mean outcomes
(QALYs or maltreatment outcome measures) between the
trial comparators. The nonparametric bootstrapping ap-
proach was used to determine the level of sampling uncer-
tainty surrounding the mean ICERs by generating 10,000
estimates of incremental costs and benefits, represented
graphically on four quadrant cost-effectiveness planes. Cost-
effectiveness acceptability curves (CEACs) showing the prob-
ability that the gFNP program is cost-effective relative to
standard care across a range of cost-effectiveness thresholds
were also generated based on the proportion of bootstrap
replicates with positive incremental net benefits. Several sen-
sitivity analyses were undertaken to assess the impact of un-
certainty surrounding components of the economic
evaluation. These included: (1) adopting a wider societal per-
spective, (2) restricting the analyses to complete cases, and
(3) recalculating the average cost per gFNP session per at-
tending woman by varying (1) the mean number of gFNP
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sessions attended to the highest and lowest observed mean
values across all groups across all sites and (2) the number of
gFNP group participants to the highest and lowest number
of observed values across all groups across all sites. Subgroup
analyses were conducted for the main cost-effectiveness re-
sults by: (1) program completers (no, yes) where women
who participated in a pre-specified number of group sessions
(at least 17 sessions) were regarded as “program completers”
and (2) program phase (1, 2, 3) to test whether organizational
learning may have influenced the cost-effectiveness of the
gFNP program. Analyses for the economic evaluation were
conducted using Stata software version 14.
Results
Between 22 August 2013 and 17 September 2014, 492
names of potential participants were received; 286 were
definitely eligible, and 166 agreed to participate with 99
randomly assigned to receive gFNP and 67 to usual care
(see Fig. 1). After recruitment, two women in the interven-
tion arm were found to be ineligible (one was outside the
FNP service area, one had received FNP). All follow-up
data were retrieved by February 2016. Participants in the
two randomized arms appear comparable at baseline in
terms of their demographic characteristics (see Table 2). Al-
though information from follow-up at around 2 months
Fig. 1 Trial consolidated standards of reporting trials (CONSORT) diagram
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Table 2 Sociodemographic characteristics at baseline
gFNP
(N = 97)
Usual care
(N = 67)
Age at last menstrual period, mean (SD) 21 · 0 (1 · 8) 21 · 2 (1 · 8)
Educational qualifications – GCSEs or equivalent?
Yes 73 (75 · 3%) 55 (82 · 1%)
No 24 (24 · 7%) 12 (17 · 9%)
GCSEs, mean (SD) 6 · 7 (3 · 1)
n = 70
6 · 4 (2 · 7)
n = 54
GCSEs, grade C or higher, mean (SD) 3 · 8 (3 · 6)
n = 69
3 (2 · 5)
n = 53
Educational qualifications – other?
Yes 79 (82 · 3%) 56 (83 · 6%)
No 17 (17 · 7%) 11 (16 · 4%)
Ethnicity
White – British 61 (63 · 5%) 48 (71 · 6%)
White – Irish 2 (2 · 1%) 0 (0 · 0%)
Any other White background 2 (2 · 1%) 3 (4 · 5%)
Asian British – Pakistani 5 (5 · 2%) 5 (7 · 5%)
Asian British – Bangladeshi 1 (1 · 0%) 0 (0 · 0%)
Black British – Caribbean 14 (14 · 6%) 6 (9 · 0%)
Black British – African 3 (3 · 1%) 2 (3 · 0%)
Mixed 8 (8 · 3%) 3 (4 · 5%)
Current partner?
Yes 83 (85 · 6%) 59 (88 · 1%)
No 14 (14 · 4%) 8 (11 · 9%)
Current partner biological father of expected child?
Yes 83 (100%) 59 (100%)
Marital status
Married 10 (10 · 4%) 8 (11 · 9%)
Unmarried/co-habiting 43 (44 · 8%) 37 (55 · 2%)
Single 43 (44 · 8%) 22 (32 · 8%)
Number of people currently living with, mean (SD) 2 · 9 (1 · 5) n = 96 3 · 1 (1 · 6)
Current household membership
Own mother/parents 11 (11 · 7%) 7 (10 · 9%)
Husband/partner 24 (25 · 5%) 24 (37 · 5%)
Husband/partner and others (not own mother) 10 (10 · 6%) 6 (9 · 4%)
Own mother/parents and others, not husband/partner 14 (14 · 9%) 10 (15 · 6%)
Own mother/parents and others, with husband/partner 6 (6 · 4%) 5 (7 · 8%)
Husband/partner and others 2 (2 · 1%) 3 (4 · 7%)
Other adults 12 (12 · 8%) 6 (9 · 4%)
Lives alone 15 (16 · 0%) 3 (4 · 7%)
Type of accommodation
House or bungalow 68 (70 · 1%) 49 (73 · 1%)
Flat, low-rise 12 (12 · 4%) 5 (7 · 5%)
Flat, high-rise, first 3 floors 5 (5 · 2%) 12 (17 · 9%)
Flat, high-rise, above 3rd floor 4 (4 · 1%) 0 (0 · 0%)
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postpartum was collected for 144 participants (84 inter-
vention and 60 control), 16 (nine intervention, seven
control) were out of the agreed time window, leaving
128 (75 intervention, 53 control). From the follow-up
at around 6 months postpartum information was
collected for 137 participants (82 intervention and 55
control); however, 16 (12 intervention, four control)
were out of the agreed time window leaving 121 (70
intervention, 51 control) (Fig. 1). Although 138 12-
month interviews were carried out (81 intervention, 57
control), seven (six intervention, one control) were out
of the agreed time window, leaving 131 (75 interven-
tion, 56 control) eligible for the primary analysis. The
primary analysis for the CARE Index (co-primary out-
come) was based on 101 videos (57 intervention, 44
control) (see Fig. 1).
Miscarriage or termination in early pregnancy, before the
time that participants could begin attending gFNP sessions,
was identified for five of the intervention-arm participants,
with one other suspected but not confirmed, and for one
control arm member. There was one late loss of pregnancy
in the eighth month for an intervention participant and one
infant death occurred at 3 months for a member of the
control arm (see Fig. 1).
The 97 trial participants in the intervention arm were allo-
cated to 16 planned groups; five sites planned for two groups
and two sites planed for three. In addition, one participant
attended sessions offered in both groups as the first group
was terminated prematurely. Overall, the 97 trial participants
in the intervention arm attended a mean of 10 · 3 sessions
(SD 13 · 4) but a substantial proportion (39, 40%) did not at-
tend any sessions. Of the 97, 17 were never allocated a gFNP
ID number by the relevant gFNP team. Reasons were: six
were contacted and refused gFNP; three were contacted and
agreed but did not attend any sessions; one miscarried by the
time the team contacted them; one moved away; two were
not contactable; with no information provided for four.
Twenty-two of the remaining 80 registered for gFNP did not
attend any sessions, 10 of whom were allocated to groups
that did not offer any sessions due to low enrollment. Five of
those were offered FNP and others were referred back to
existing services. Thus, of the 97 allocated to the intervention
arm, 58 took part in at least one gFNP session.
There was no suggestion of an important effect of gFNP
on either of the two primary outcomes in the ITT analysis
based on outcomes available within the agreed time frame
(AAPI-2, N = 131, CARE Index N = 101): the AAPI-2 [22]
total was 7 · 5/10 (SE 0 · 1) in both arms (difference
Table 2 Sociodemographic characteristics at baseline (Continued)
gFNP
(N = 97)
Usual care
(N = 67)
Room or bedsit 2 (2 · 1%) 1 (1 · 5%)
Hostel 2 (2 · 1%) 0 (0 · 0%)
Supported housing 1 (1 · 0%) 0 (0 · 0%)
Group home/shelter 2 (2 · 1%) 0 (0 · 0%)
Other 1 (1 · 0%) 0 (0 · 0%)
Enrolled in any school or educational program?
Yes 12 (12 · 4%) 9 (13 · 4%)
No 85 (87 · 6%) 58 (86 · 6%)
Course details
School, up to year 11 1 (8 · 3%) 0 (0 · 0%)
School, year 12 or 13 or 6th form college 1 (8 · 3%) 0 (0 · 0%)
Access course 1 (8 · 3%) 1 (11 · 1%)
Vocational course 6 (50 · 0%) 2 (22 · 2%)
University 3 (25 · 0%) 6 (66 · 7%)
Ever employed?
Yes 76 (78 · 4%) 56 (83 · 6%)
No 21 (21 · 7%) 11 (16 · 4%)
Currently employed?
Yes, full-time 30 (39 · 5%) 28 (50 · 0%)
Yes, part-time 14 (18 · 4%) 8 (14 · 3%)
No 32 (42 · 1%) 20 (35 · 7%)
GCSE General Certificate of Education, taken usually at age 15/16 years; generally required before any further educational course can be taken, gFNP Group Family
Nurse Partnership, SD standard deviation
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adjusted for baseline, site and maternal age group 0 · 06;
see Additional file 1: Table S1 for baseline) (95% CI − 0 ·
15 to 0 · 28, p = 0 · 59); and mother’s sensitivity using the
CARE Index [23] was mean 4 · 0 in the intervention arm
(SE 0 · 3) and 4 · 7 in the control arm (SE 0 · 4) (difference
adjusted for site and maternal age group − 0 · 68, 95% CI
− 1 · 62 to 0 · 16, p = 0 · 25) (see Table 3).
Using a complier average causal effect (CACE) analysis
[31] to take account of compliance made very little dif-
ference to the ITT results for the AAPI-2 either when
compliance was defined as attending at least one group
session (difference 0 · 13, 95% CI − 0 · 41 to 0 · 69, p = 0 ·
64) or when compliance was defined as attending at
least 17 group sessions (difference 0 · 17, 95% CI − 0 · 91
to 1 · 24, p = 0 · 76). The corresponding results for
mother’s sensitivity in the CARE Index are difference −
1 · 29, 95% CI − 2 · 78 to 0 · 19, p = 0 · 09 when compli-
ance was defined as attending at least one group session,
and difference − 2 · 61, 95% CI − 5 · 57 to 0 · 35, p = 0 · 08
when compliance was defined as attending at least 17
group sessions (see Table 4).
There is no evidence of any effect of the intervention
on any of the eight pre-specified secondary outcomes
(see Table 3) with the exception that the proportion of
women still breastfeeding at 6 months is higher in the
intervention arm (adjusted OR 3 · 2 (0 · 99, 10 · 6); p = 0 ·
05). The sensitivity analyses including all participants ir-
respective of whether they were within the pre-specified
time window (see Additional file 1: Table S2) supported
the findings of the primary and secondary analyses.
Economic costs for women with complete data are
presented in the Additional file 1: Table S3, by trial arm,
study period and cost category. Adopting a study per-
spective of the NHS and personal social services (PSS)
and measuring health outcomes in terms of QALYs, the
average total cost was £8179 in the gFNP intervention
arm, compared with £6107 in the control arm, generat-
ing a mean incremental cost of £2072. The mean incre-
mental cost-effectiveness of gFNP was estimated at −
£247,485 per QALY gained, i.e., on average the intervention
was associated with a net positive cost and a net negative
effect (see Table 5). Regardless of the value of the cost-
effectiveness threshold, the probability that gFNP is cost-
effective does not exceed 3% (see Fig. 2). This pattern of re-
sults was broadly replicated when outcomes were measured
using the CARE Index maternal sensitivity [23]. It is
Table 3 Primary and secondary outcomes and estimated Group Family Nurse Partnership (gFNP) intervention effects at 12 months
Measure gFNP Usual care Unadjusted effect estimatea Adjusted effect estimateb
Mean (SE) Mean (SE) Difference (95% CI) p value Difference (95% CI) p value
AAPI-R N = 75 N = 56
Total (/10) 7 · 5 (0 · 1) 7 · 5 (0 · 1) 0 · 05 (−0 · 17, 0 · 24) 0 · 68 0 · 06 (− 0 · 15, 0 · 28) 0 · 59
CARE Index N = 57 N = 44
Mother’s sensitivity (/14) 4 · 0 (0 · 3) 4 · 7 (0 · 4) − 0 · 76 (− 1 · 68, 0 · 13) 0 · 22 − 0 · 68 (− 1 · 62, 0 · 16) 0 · 25
Infant cooperativeness (/14) 3 · 0 (0 · 3) 3 · 5 (0 · 3) − 0 · 49 (− 1 · 25, 0 · 34) 0 · 38 − 0 · 45 (− 1 · 25, 0 · 33) 0 · 42
Depression, EPDS N = 83 N = 59
Total (/30) 3 · 8 (0 · 5) 4 · 1 (0 · 6) − 0 · 07 (− 0 · 76, 0 · 62) 0 · 85 0 · 05 (− 0 · 68, 0 · 77) 0 · 90
Parenting stress, PSI N = 83 N = 58 N = 83 N = 58
Total (/180) 73 · 4 (1 · 5) 74 · 9 (2 · 0) − 0 · 97 (− 3.65, 1.70) Total (/180) 73 · 4 (1 5) 74 · 9 (2 · 0)
Parenting competence (PSOC) N = 81 N = 58
Total (/102) 60 · 9 (0 · 4) 60 · 7 (0 · 6) − 0 · 12 (− 0 · 92, 0 · 67) 0 · 76 − 0 · 18 (− 1.03, 0 · 67) 0 · 68
Social support, MOS N = 73 N = 55
Total (/100) 84 · 6 (2 · 2) 84 · 5 (2 · 3) − 0 · 59 (− 5 · 71, 4 · 53) 0 · 82 − 0 · 45 (− 5.45, 4 · 59) 0 · 85
Relationships, abuse N = 75 N = 56
Total (/6) 0 · 4 (0 · 1) 0 · 5 (0 · 1) − 0 · 07 (− 0 · 39, 0 · 19) 0 · 63 − 0 · 10 (− 0 · 40, 0 · 17) 0 · 47
Smoking, alcohol, drug use N = 75 N = 56
Total (/24) 17 (0 · 3) 16 · 6 (0 · 3) − 0 · 2 (− 1 · 19, 0 · 79) 0 · 71 − 0 · 20 (− 1 · 16, 0 · 82) 0 · 70
Breastfeeding at 6 months? N = 70 N = 51
Yes 15 (21 · 4) 4 (7 · 8) 3 · 2 (0 · 99, 10 · 3) 0 · 05 3 · 46 (1.02, 11.75) 0 · 05
No 55 (78 · 6) 47 (92 · 2) 1
aAnalysis of covariance – adjusted for baseline where possible
bAdjusted where possible for baseline, and for site and maternal age group
Note: CI confidence interval, AAPI-2 Revised Adult-Adolescent Parenting Inventory, EPDS Edinburgh Postnatal Depression Scale, PSI Parenting Stress Index, PSOC
Parenting Sense of Competence, MOS Medical Outcomes Study Social Support Survey, SE standard error
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notable, however, that when outcomes were measured in
terms of change in AAPI-2 [22] score between baseline and
12 months postpartum, the gFNP intervention was associ-
ated with a positive health effect (mean incremental gain in
AAPI-2 score 0 · 02). For this outcome measure, the prob-
ability that gFNP is cost-effective reached 25 · 1% at a
notional £20,000 cost-effectiveness threshold.
Sensitivity analyses were also conducted on the
economic data. Broadening the study perspective to that
of society as a whole had little effect on the results. In
particular, when the QALY metric was adopted as the
primary outcome measure, the mean ICER remained in
the north-west quadrant of the cost-effectiveness plane
and the probability that gFNP is cost effective at a
£20,000 cost-effectiveness threshold remained at 2 · 5%.
Increasing the mean number of gFNP sessions attended
to the highest number of sessions observed across all
groups across all sites and increasing the number of
gFNP group participants to the highest number of
participants observed across all groups across all sites
had the effect of decreasing the mean cost difference
between the trial arms. Nevertheless, the mean ICER for
gFNP remained in the north-west quadrant of the cost-
effectiveness plane, and the probability of cost-effectiveness
for the intervention did not exceed 20% at a £20,000 cost-
effectiveness threshold. Pre-specified subgroup analyses re-
vealed no evidence that either program completion or the
program phase had a positive effect on the cost-
Table 5 Baseline cost-effectiveness based upon quality-adjusted life year (QALY) and primary outcomes: imputed data, NHS and PSS
perspectivea
Outcome Measure Mean costs (95% CI) Mean effects (95% CI) Probability that gFNP is
gFNP
(£)
Usual
care (£)
Difference
(£)
gFNP Usual
care
Difference ICER (£) More
effectiveb
(%)
Less
costlyb
(%)
Cost-
effectiveb
(%)#
Cost-
effectiveb
(%)±
Cost-
effectiveb
(%)∞
QALY [28] N = 97 N = 67 N =
97
N =
67
8179
(5397,
10961)
6107
(5029,
7184)
2072
(− 843,
4988)
0 · 92
(0 · 84,
1 · 00)
0 · 93
(0 · 85,
1 · 00)
− 0 · 01
(− 0 · 05,
0 · 03)
− 247,485
(NW)
19 · 2 2 · 8 2 · 0 2 · 3 3 · 0
AAPI-2 [22] N = 97 N = 67 N =
97
N =
67
8179
(5903,
10455)
6107
(5160,
7054)
2072
(− 392,
4537)
0 · 27
(0 · 14,
0 · 40)
0 · 25
(0 · 12,
0 · 38)
0 · 02
(− 0 · 17,
0 · 21)
111,334
(NE)
58 · 4 1 · 9 19 · 1 25 · 1 32 · 9
CARE Index
maternal sensitivity
[23]
N = 97 N = 67 N =
97
N =
67
8179
(5903,
10455)
6107
(5160,
7054)
2072
(− 392,
4537)
3 · 97
(3 · 54,
4 · 39)
4 · 84
(4 · 30,
5 · 38)
− 0 · 87
(− 1 · 55,
− 0 · 19)
− 2382
(NW)
1 · 2 1 · 4 < 1 < 1 < 1
a(£, 2014–2015 prices), bBased on 10,000 bootstrap replicates of the dataset
The gFNP intervention was considered to be “cost-effective” if it had positive net benefit at a: #GBP £15,000 cost-effectiveness threshold, ±GBP £20,000 cost-
effectiveness threshold, ∞GBP £30,000 cost-effectiveness threshold
gFNP Group Family Nurse Partnership, GBP, pounds sterling, NHS National Health Service, PSS personal social services, CI confidence interval, ICER incremental
cost-effectiveness ratio, NW north-west quadrant of cost-effectiveness plane, NE north-east quadrant of the cost-effectiveness plane, QALY quality-adjusted life
years, AAPI-2 Adult-Adolescent Parenting Inventory
Table 4 Primary outcomes and estimated intervention effects at 12 months − complier average causal effect estimates
Measure gFNP N = 75 Usual care N = 56 Unadjusted effect
estimatea
Difference (95% CI)
p
Mean (SE) Mean (SE)
Adult-Adolescent Parenting Inventory-2 [22]
Total (/10) attended at least 1 session 7 · 6 (0 · 2) 7 · 4 (0 · 2) 0 · 13 (− 0 · 41, 0 · 69) 0 · 64
Total (/10) attended at least 17 sessions 7 · 9 (0 · 2) 7 · 8 (0 · 5) 0 · 17 (− 0 · 91, 1 · 24) 0 · 76
CARE Index maternal sensitivity [23]
Total (/10) attended at least 1 session 4 · 1 (0 · 3) 5 · 4 (0 · 7) − 1 · 29 (− 2 · 78, 0 · 19) 0 · 09
Total (/10) attended at least 17 sessions 4 3 (0 · 5) 6 · 4 (1 · 5) − 2 · 61 (− 5 · 57, 0 · 35) 0 · 08
aAnalysis of covariance – (adjusted for baseline)
Note: the numbers in the control group column are the means of the sample of the controls that would have expected to have been compliers had they received
the intervention
CI confidence interval, gFNP group Family Nurse Partnership, SE standard error
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effectiveness of the gFNP program (see Additional file 1:
Tables S4 to S7).
Discussion
Neither the main intention-to-treat analyses nor the
CACE analysis, in which comparisons focused on
mothers who had attended either at least one session or
at least 17, identified any evidence that the gFNP
program, compared to routine antenatal and postnatal
services, could reduce risk factors for maltreatment
based on mothers’ attitudes to parenting and sensitive
behavior when interacting with their 1-year-old infants.
Only one of eight secondary outcomes showing evidence
of a positive impact of gFNP (women in the intervention
arm of the trial were more likely to breastfeed their baby
up to 6 months) which aligns with the World Health
Organization’s (WHO) recommendations [36], and may
also have some potential for enhancing other parenting
behaviors such as maternal sensitivity [37]. Overall, and
contrary to the prediction, this study did not show that
the gFNP program is more effective than usual care for
reducing the likelihood of child maltreatment with this
population of young and potentially vulnerable mothers,
and the economic evaluation demonstrated that it is
more costly than treatment as usual. This reflects the find-
ings of a recent UK trial of the related home delivered
FNP program which also did not identify any impact on
the likelihood of child maltreatment, although secondary
outcomes related to child language were positive [5].
However, the overall results need to be considered in
the context of the threat to external validity due to slow
recruitment [16], which affected the size of groups, the
extent of attrition and, in some cases, whether or not a
sufficient number were recruited to run a group at all.
Many months of preparation notwithstanding, it proved
challenging to identify potential participants, the main con-
sequence being that almost all the groups delivered were
suboptimal in terms of the number of clients, meaning that
dynamic exchange between group members in terms of be-
liefs or parenting practices, and between group members
and the FNs facilitating the groups, may have been reduced.
The groups delivered in pilot work were larger [13] and
Fig. 2 Cost-effectiveness plane and cost-effectiveness acceptability curve based upon the quality-adjusted life year (QALY) outcome: imputed
data, National Health Service (NHS) and personal social services (PSS) perspective (£, 2014–2015 prices)
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many participants perceived substantial benefits, in particu-
lar in terms of one of the secondary outcomes in this study,
social support, which nevertheless was not shown to be af-
fected by gFNP in this trial. Retention at trial follow-up was
good, which reinforces the view that initial identification of
participants [16] was the primary reason for difficulties in
setting up and maintaining groups.
The Dutch trial of FNP [7] offered it to a population
with several vulnerabilities. Increasing the vulnerability
criteria for eligibility to gFNP might have increased the
potential of the study to identify an impact, but to estab-
lish groups of sufficient size with women who live in
close proximity to each other and also to have similar
due dates, would require fewer and not more eligibility
requirements which would make evaluation a challenge.
Basing eligibility on more criteria would also require
more information to be available in antenatal records.
Changes in recording systems and restricted access for
primary care and maternity care could mean that the
identification of potential participants with more risk
factors would be challenging, reflecting the difficulties
faced in this trial [16].
Implementation studies of gFNP found that program
delivery could be sustained if groups started with be-
tween eight and twelve members [13]. A number of per-
ceived impacts were also identified, though they mainly
focused on increased social support, the capacity to
manage relationships successfully, and maternal confi-
dence [13, 17]. These were examined as secondary out-
comes in this trial but did not show any difference from
women assigned to usual care, which suggests that the
UK Healthy Child Program [10] may provide families
with sufficient support in terms of these outcomes.
Nevertheless it is worth noting that mothers in both
arms of the trial had below average CARE Index sensi-
tivity scores placing them only just above the high-risk
range (0–4) [23]. Thus, these young women, relatively
new or new to parenting, may have benefitted from a
group intervention that focuses specifically on enhancing
playful, stimulating and sensitive mother-infant activ-
ities, such as the Australian Community HUGS program
[38]. Alternatively, while group support starting in preg-
nancy may help with building social capital, specific par-
enting practices or attitudes may be best enhanced with
postnatal programs such as video-interaction guidance
[39] or parent-infant psychotherapy [40].
Conclusions
In conclusion, it has been shown in RCTs in the USA
[6], and in Europe [7], though not in England [5], that a
home-based, nurse-delivered program, Nurse Family
Partnership (NFP, in the UK Family Nurse Partnership,
FNP) starting in pregnancy and continuing until infants
are 24 months, reduces the likelihood of child
maltreatment when offered to potentially vulnerable,
young, first-time mothers. The gFNP program was de-
veloped prior to the publication of the UK trial of FNP
to have similar objectives. In retrospect, if the UK trial
results had been available, the development of gFNP
might have focused more on sensitive parenting and
child protection in the knowledge of the minimal impact
in the UK of one-to-one FNP on outcomes indicative of
a risk for maltreatment, or maltreatment itself.
Implementation evaluations of gFNP found that it was
acceptable to the target population and to the nurses de-
livering the program with perceived positive benefits,
such as greater parenting competence, though much of
the impact was thought to be in relation to social sup-
port and infant development [13]. This RCT study has
shown, however, that the gFNP program with this UK
population is not a cost-effective means of supporting
parenting and reducing the risk of child maltreatment in
comparison with existing universal services. Further de-
velopment and refinement of the program is recom-
mended prior to any subsequent implementation or
evaluation. Finally, any subsequent evaluation of gFNP
will need strong involvement of local midwifery teams to
identify potential participants in early pregnancy as effi-
ciently as possible.
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